{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:41:25Z","timestamp":1764715285513,"version":"3.41.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Contrast medium is frequently associated with allergic reactions and kidney dysfunction. However, contrast media can induce hemolytic anemia with a broad spectrum of hemolytic manifestations. We report a 38-year-old patient with very severe immune hemolytic anemia after the application of iomeprol due to a CT of the thorax\/abdomen. In this case report, we illustrate the diagnostics and treatment of life-threatening hemolytic anemia induced by a contrast medium that was successfully treated with eculizumab.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1464014","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T07:04:14Z","timestamp":1739257454000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Sabine","family":"Hermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Althaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Migdat","family":"Mustafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene Anna","family":"Haeberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e14522","DOI":"10.7759\/cureus.14522","article-title":"Contrast media-induced immune hemolytic anemia","volume":"13","author":"Al Ghailani","year":"2021","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.2018.58.issue-9","article-title":"Immune hemolysis secondary to injection of contrast medium","volume":"58","author":"Maurin","year":"2018","journal-title":"Transfusion"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/trf.2013.53.issue-10","article-title":"Intravascular immune hemolysis caused by the contrast medium iomeprol","volume":"53","author":"Mayer","year":"2013","journal-title":"Transfusion"},{"key":"B4","article-title":"Immune-mediated hemolysis associated with the administration of a radiographic contrast medium","volume":"31","author":"Nordhagen","year":"1991","journal-title":"Transfusion"},{"key":"B5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/voxs.2019.14.issue-1","article-title":"Drug-induced immune haemolytic anaemias","volume":"14","author":"Branch","year":"2019","journal-title":"ISBT Sci Ser"},{"key":"B6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40360-018-0257-7","article-title":"Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature","volume":"19","author":"Leicht","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.114561","article-title":"Treatment of autoimmune hemolytic anemias","volume":"99","author":"Zanella","year":"2014","journal-title":"Haematologica"},{"key":"B8","doi-asserted-by":"publisher","first-page":"363278","DOI":"10.1155\/2015\/363278","article-title":"Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy","volume":"2015","author":"Berentsen","year":"2015","journal-title":"BioMed Res Int"},{"key":"B9","article-title":"Diagnosis and treatment of the immune hemolytic anemias","volume":"14","author":"Rosenfield","year":"1981","journal-title":"Haematologia (Budap)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"102621","DOI":"10.1016\/j.bcmd.2021.102621","article-title":"Systemic corticosteroids in the treatment of warm autoimmune hemolytic anemia: A clinical setting perspective","volume":"92","author":"Abdallah","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1309\/AJCPBVLJZH6W6RQM","article-title":"Pathology consultation on drug-induced hemolytic anemia","volume":"136","author":"Pierce","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9181698","DOI":"10.1155\/2016\/9181698","article-title":"Refractory igG warm autoimmune hemolytic anemia treated with eculizumab: A novel application of anticomplement therapy","volume":"2016","author":"Ma","year":"2016","journal-title":"Case Rep Hematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: the last 30 years of changes","volume":"30","author":"Arndt","year":"2014","journal-title":"Immunohematology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1464014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T07:04:19Z","timestamp":1739257459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1464014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":13,"alternative-id":["10.3389\/fimmu.2025.1464014"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1464014","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"article-number":"1464014"}}